17-50518982-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032133.6(MYCBPAP):āc.661A>Gā(p.Lys221Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000347 in 1,613,616 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032133.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYCBPAP | NM_032133.6 | c.661A>G | p.Lys221Glu | missense_variant | 6/19 | ENST00000323776.11 | NP_115509.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYCBPAP | ENST00000323776.11 | c.661A>G | p.Lys221Glu | missense_variant | 6/19 | 1 | NM_032133.6 | ENSP00000323184.6 | ||
MYCBPAP | ENST00000452039.7 | c.706A>G | p.Lys236Glu | missense_variant | 6/19 | 5 | ENSP00000407145.3 | |||
MYCBPAP | ENST00000437498.2 | n.661A>G | non_coding_transcript_exon_variant | 6/21 | 2 | ENSP00000414583.2 | ||||
MYCBPAP | ENST00000470609.5 | n.911A>G | non_coding_transcript_exon_variant | 6/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251158Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135862
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461438Hom.: 0 Cov.: 32 AF XY: 0.0000385 AC XY: 28AN XY: 727056
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.790A>G (p.K264E) alteration is located in exon 6 (coding exon 6) of the MYCBPAP gene. This alteration results from a A to G substitution at nucleotide position 790, causing the lysine (K) at amino acid position 264 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at